Visceral leishmaniasis vaccine (IDRI)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameVisceral leishmaniasis vaccine (IDRI)
Drug Alias Name内脏利什曼病疫苗 - IDRILEISH-F3 + GLA-SE
ClassificationVaccines > Application > Prophylactic vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsLeishmaniasis, VisceralLeishmaniasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInfectious Disease Research InstituteBill And Melinda Gates Foundation
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInfectious Disease Research InstituteAccess to Advanced Health InstituteZydus Cadila +[6] 
Active IndicationsN/A
Inactive IndicationsLeishmaniasis, VisceralLeishmaniasis

Other Information

ATC CodeN/A
Related LinksN/A